CD4 ‐Derived Double‐Negative T Cells Ameliorate Alzheimer's Disease‐Like Phenotypes in the 5× FAD Mouse Model
CNS Neuroscience & Therapeutics · 2025-01 · 31 (1)
DOI: 10.1111/cns.70187 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 23.01.2025. Verfasst von Yuanzi Xie und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Alzheimer Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Basic Frontier Science Research Program of CAS, Strategic Priority Research Program of CAS.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer's disease (AD) is a debilitating neurodegenerative disorder that is difficult to predict and is typically diagnosed only after symptoms manifest. Recently, CD4 + T cell‐derived double‐negative T (DNT) cells have shown strong immuno‐regulatory properties in both in vitro and in vivo neuronal inflammation studies. However, the effectiveness of DNT cells in treating on AD are not yet fully understood.
Objective
This study's aims were three‐fold, to (1) evaluate the efficacy of CD4 + T cell‐derived DNT cells treatment on AD mice, (2) understand how DNT treatment make changes in different cell types of 5FAD mice, (3) identify the side effects of DNT treatment.
Methods
We performed tail vein injection of transformed and amplified CD4 + T cell‐derived DNT cells into 5 × FAD mice, while using WT mice and saline injection 5FAD mice as controls. DNT suspensions or NaCl alone were administered to 5 × FAD mice at the 6 months of age. For intravenous injection ( n = 10 for both DNT and control injections), 5 × FAD mice were injected with a total of 5 × 10 6 DNT cells suspended in 200 μL of 0.9% NaCl or 0.9% NaCl alone via the lateral tail vein. Behavioral tests and pathology tests were carried out 30 days after cell transplantation.
Results
Through qualitative analysis, we identified 6 main themes. DNT from young wild‐type mice enhance the capability of spatial learning and memory in AD mice. DNT cell treatment rejuvenates the microglial function. DNT cell treatment improves the state of oligodendrocytes. DNT cell treatment finetunes the activation of the immune system. DNT cell treatment improves the synaptic plasticity and increases the complexity of neurons. DNT cell treatment reduces the density of amyloid Beta plaques deposition in the cortex and hippocampus of 5 × FAD mice.
Discussion
The findings from this study reveal that DNT treatment improved spatial memory and learning abilities, reduced Aβ deposition, and enhanced synaptic plasticity, contrasting with previous reports on thymus‐derived DNT cells. Additionally, CD4 + T cell‐derived DNT therapy exhibited anti‐inflammatory effects and modulated microglial function, promoting a neuroprotective environment. Notably, DNT treatment also reduced tau pathology by decreasing levels of abnormally phosphorylated tau. These findings suggest that CD4 + T cell‐derived DNT cells hold therapeutic potential for AD, effectively targeting both Aβ and tau pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
- University of Chinese Academy of Sciences, Beijing, China.
- Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
- Beijing Clinical Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
- Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
- Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
ORCID-Profile: Baoyang Hu
Förderung
- National Key Research and Development Program of China
- Basic Frontier Science Research Program of CAS
- Strategic Priority Research Program of CAS
Zitieren
APA
Xie, Y., Liu, J., Hou, Z., Wang, H., Liu, K., Chen, X., Fan, Z., Li, D., Li, C., Pan, Y., Zhao, Y., Zhu, Y., & Hu, B. (2025). CD4 ‐Derived Double‐Negative T Cells Ameliorate Alzheimer's Disease‐Like Phenotypes in the 5× FAD Mouse Model. CNS Neuroscience & Therapeutics, 31(1). https://doi.org/10.1111/cns.70187
Vancouver
Xie Y, Liu J, Hou Z, Wang H, Liu K, Chen X, et al. CD4 ‐Derived Double‐Negative T Cells Ameliorate Alzheimer's Disease‐Like Phenotypes in the 5× FAD Mouse Model. CNS Neuroscience & Therapeutics. 2025;31(1). doi:10.1111/cns.70187
BibTeX
@article{Xie2025,
author = {Xie, Yuanzi and Liu, Jing and Hou, Zongren and Wang, Huan and Liu, Kailun and Chen, Xiaowei and Fan, Zhen and Li, Da and Li, Can and Pan, Yuhualei and Zhao, Yushang and Zhu, Yanbing and Hu, Baoyang},
title = {CD4 ‐Derived Double‐Negative T Cells Ameliorate Alzheimer's Disease‐Like Phenotypes in the 5× FAD Mouse Model},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {1},
doi = {10.1111/cns.70187}
}
EUVIMED